Cargando…
Soluble Neprilysin ― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―
Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...
Autores principales: | Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889477/ https://www.ncbi.nlm.nih.gov/pubmed/33693148 http://dx.doi.org/10.1253/circrep.CR-19-0034 |
Ejemplares similares
-
Soluble neprilysin does not correlate with prognosis in pulmonary hypertension
por: Yoshihisa, Akiomi, et al.
Publicado: (2019) -
Plasma levels of melatonin in dilated cardiomyopathy
por: Misaka, Tomofumi, et al.
Publicado: (2019) -
Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy
por: Yokokawa, Tetsuro, et al.
Publicado: (2021) -
Soluble fibrin monomer complex is associated with cardio- and cerebrovascular events in patients with heart failure
por: Yoshihisa, Akiomi, et al.
Publicado: (2020) -
Blood‐Based Epigenetic Markers of FKBP5 Gene Methylation in Patients With Dilated Cardiomyopathy
por: Wada, Kento, et al.
Publicado: (2021)